OMX Nordic 40
2 298,46
|
5,44
|
0,24 %
|
Analysen zu OMX Nordic 40-Werten
11.09.24 | ABB Neutral | JP Morgan Chase & Co. | |
10.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
10.09.24 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
10.09.24 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
09.09.24 | AstraZeneca Sell | UBS AG | |
09.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
09.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
06.09.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
03.09.24 | Volvo AB Buy | Jefferies & Company Inc. | |
03.09.24 | Volvo AB Sector Perform | RBC Capital Markets | |
03.09.24 | ABB Sector Perform | RBC Capital Markets | |
03.09.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
30.08.24 | Hennes & Mauritz AB Overweight | Barclays Capital | |
28.08.24 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
28.08.24 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
28.08.24 | Novo Nordisk Buy | Deutsche Bank AG | |
28.08.24 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
27.08.24 | Hennes & Mauritz AB Outperform | RBC Capital Markets | |
27.08.24 | Volvo AB Buy | Goldman Sachs Group Inc. | |
15.08.24 | AstraZeneca Sell | UBS AG | |
15.08.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
14.08.24 | Volvo AB Buy | Jefferies & Company Inc. | |
13.08.24 | AstraZeneca Sell | UBS AG | |
13.08.24 | Hennes & Mauritz AB Buy | Deutsche Bank AG | |
09.08.24 | Novo Nordisk Neutral | UBS AG | |
08.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
08.08.24 | A.P. Moeller - Maersk A-S Underperform | Bernstein Research | |
07.08.24 | Novo Nordisk Underperform | Bernstein Research | |
07.08.24 | Novo Nordisk Neutral | UBS AG | |
07.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
07.08.24 | A.P. Moeller - Maersk A-S Neutral | Goldman Sachs Group Inc. | |
07.08.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
07.08.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
05.08.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
01.08.24 | Novo Nordisk Neutral | UBS AG | |
31.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
30.07.24 | Volvo AB Sector Perform | RBC Capital Markets | |
30.07.24 | ABB Buy | Goldman Sachs Group Inc. |